Literature DB >> 4341272

Use of the 51 Cr release test to demonstrate patterns of antibody response in humans to herpesvirus types 1 and 2.

J W Smith, E Adam, J L Melnick, W E Rawls.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4341272

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  19 in total

1.  Cell-mediated immunity to Herpes simplex in humans: lymphocyte cytotoxicity measured by 51-Cr release from infected cells.

Authors:  A S Russell; J S Percy; T Kovithavongs
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

2.  Studies on the neutralizing antibody to herpes simplex virus. II. Quantitative analysis of type specific antibodies in rabbits immunized with both types of virus.

Authors:  M Ohashi; Y Ozaki
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

3.  Isolation of the major herpes simplex virus type 1 (HSV-1)-specific glycoprotein by hydroxylapatite chromatography and its use in enzyme-linked immunosorbent assay for titration of human HSV-1-specific antibodies.

Authors:  B F Vestergaard; P C Grauballe
Journal:  J Clin Microbiol       Date:  1979-12       Impact factor: 5.948

4.  Solid phase radioimmunoassay for typing herpes simplex viral antibodies in human sera.

Authors:  B Forghani; N J Schmidt; E H Lennette
Journal:  J Clin Microbiol       Date:  1975-11       Impact factor: 5.948

5.  Human antibody-dependent cell-mediated cytotoxicity against target cells infected with respiratory syncytial virus.

Authors:  R Scott; M O de Landazuri; P S Gardner; J J Owen
Journal:  Clin Exp Immunol       Date:  1977-04       Impact factor: 4.330

6.  Flow cytometric indirect immunofluorescence assay with high sensitivity and specificity for the detection of antibodies to HSV-1 and HSV-2.

Authors:  A Caruso; M Tinti; L Peroni; E Cabibbo; C De Rango; N Manca; A Turano
Journal:  Eur J Epidemiol       Date:  1993-09       Impact factor: 8.082

7.  Cell cytotoxicity due to specific influenza antibody production in vitro after recent influenza antigen stimulation.

Authors:  S B Greenberg; H R Six; S Drake; R B Couch
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

8.  The preparation, efficacy and safety of 'antigenoid' vaccine NFU1 (S-L+) MRC toward prevention of herpes simplex virus infections in human subjects.

Authors:  G R Skinner; A Buchan; C E Hartley; S P Turner; D R Williams
Journal:  Med Microbiol Immunol       Date:  1980       Impact factor: 3.402

9.  Comparison of indirect hemagglutination and 51chromium release tests for detection of Herpes Simplex Virus type 1 and 2 antibodies in patients with recurrent Herpes infections.

Authors:  L Kesavalu; P Seth
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

10.  Intratypic and intertypic specificity of lymphocytes involved in the recognition of herpes simplex virus glycoproteins.

Authors:  V C Carter; P L Rice; S S Tevethia
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.